Loading clinical trials...
Loading clinical trials...
The Effect of Antidepressants and Gabapentin on Tamoxifen Pharmacokinetics: A Prospective Study
Conditions
Interventions
citalopram hydrobromide
escitalopram oxalate
+9 more
Locations
6
United States
Indiana University Melvin and Bren Simon Cancer Center
Indianapolis, Indiana, United States
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, Maryland, United States
University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, United States
Mayo Clinic
Rochester, Minnesota, United States
UNC Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina, United States
Virginia Cancer Specialists PC-Arlington
Arlington, Virginia, United States
Start Date
March 16, 2011
Primary Completion Date
May 12, 2014
Completion Date
May 27, 2014
Last Updated
February 14, 2025
NCT05468034
NCT04541381
NCT07073963
NCT03137095
NCT07547774
NCT04852887
Lead Sponsor
Mayo Clinic
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions